Detalhe da pesquisa
1.
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers.
Genome Res
; 32(7): 1343-1354, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933939
2.
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.
Blood
; 132(1): 59-66, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784643
3.
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma.
Haematologica
; 105(4): 1055-1066, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221783
4.
Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
Br J Haematol
; 184(4): 578-593, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408155
5.
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
Blood
; 130(1): 30-34, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28432222
6.
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Blood
; 124(13): 2051-60, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25061178
7.
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma.
Blood
; 121(23): 4753-7, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23603914
8.
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).
Haematologica
; 100(9): 1214-21, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26022710
9.
Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.
BMC Cancer
; 15: 864, 2015 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545722
10.
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.
Cancer Cell
; 10(4): 295-307, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17045207
11.
Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.
Haematologica
; 98(1): 71-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22733020
12.
Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.
Am J Hematol
; 88(6): 463-71, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23456977
13.
EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression.
Cancers (Basel)
; 15(18)2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760488
14.
Growth and dormancy control of myeloma cells by mesenchymal stem cells.
Leuk Res
; 133: 107355, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499483
15.
Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.
Blood
; 115(1): 61-70, 2010 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19837979
16.
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.
Haematologica
; 102(9): e364-e367, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550191
17.
Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone.
Stem Cells
; 29(2): 263-73, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21732484
18.
Highly activated and expanded natural killer cells for multiple myeloma immunotherapy.
Haematologica
; 97(9): 1348-56, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22419581
19.
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype.
Haematologica
; 102(8): e313-e316, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522572
20.
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.
Blood
; 114(9): 1803-12, 2009 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19597185